{"id":3997,"date":"2021-11-22T06:54:42","date_gmt":"2021-11-22T06:54:42","guid":{"rendered":"https:\/\/cms.alj3.clients.lemonhq.io\/press-release\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/"},"modified":"2025-12-09T09:02:33","modified_gmt":"2025-12-09T09:02:33","slug":"abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east","status":"publish","type":"pressrelease","link":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/","title":{"rendered":"Abdul Latif Jameel Health to collaborate with EQRx to introduce two novel and affordable cancer treatments at a fraction of the cost of existing approaches to 1.5 billion people across the Middle East, Turkey and Africa"},"content":{"rendered":"\n<ul class=\"wp-block-list\">\n<li>Aumolertinib and Sugemalimab have both shown positive data from Phase III studies in treatment of non-small cell lung cancer and could offer treatment at a fraction of the cost of existing and traditional approaches<\/li>\n\n\n\n<li>EQRx is committed to developing new medicines, offering them at lower prices, reimagining medicine to address one of society\u2019s biggest health care challenges<\/li>\n\n\n\n<li>Founded in 2020, Abdul Latif Jameel Health was created as a response to the ongoing global disparity in access to modern medical care, focusing on accelerating healthcare inclusion across the global south<\/li>\n<\/ul>\n\n\n\n<p><a href=\"https:\/\/aljhealth.com\/en\/\">Abdul Latif Jameel Health<\/a>, part of international diversified family business <a href=\"https:\/\/media.alj.com\/en\/\">Abdul Latif Jameel<\/a>, and <a href=\"http:\/\/www.eqrx.com\">EQRx<\/a>, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at significantly lower prices, have entered into a new strategic collaboration for the commercialization of two affordable novel lung cancer therapeutics to millions of people across the Middle East, Africa and Turkey.<\/p>\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">https:\/\/www.youtube.com\/embed\/1urWzR8Ldo4<\/div><\/figure>\n\n\n<p>The two oncology programs, Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor and Sugemalimab, an anti-PD-L1 antibody, have shown promising Phase 3 data for the treatment of patients with advanced non-small cell lung cancer (NSCLC). &nbsp;<\/p>\n\n\n\n<p>These therapies may offer treatment at a fraction of the cost of existing and traditional approaches.<\/p>\n\n\n\n<p>This new strategic collaboration will see Abdul Latif Jameel Health commercialize the drugs to selected markets throughout the Middle East region, as well as in Turkey and all of Africa, providing access to affordable treatments for thousands of patients with advanced NSCLC.<\/p>\n\n\n<div class=\"wp-block-image size-medium wp-image-74165\">\n<figure class=\"alignleft\"><img decoding=\"async\" src=\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Akram_Print-200x300-1.jpg\" alt=\"Akram Bouchenaki\" class=\"wp-image-74165\"\/><figcaption class=\"wp-element-caption\">Akram Bouchenaki,<br><br>Chief Executive Officer, Abdul Latif Jameel Health<\/figcaption><\/figure>\n<\/div>\n\n\n<p><em>\u201cThis agreement comes as we forge ahead in our mission to source, collaborate with and fund innovators within the medical world that are re-examining how to improve the current healthcare landscape by disrupting existing methods and working to accelerate the wider inclusivity of healthcare throughout the world,\u201d <\/em>said <a href=\"https:\/\/www.alj.com\/en\/our-people\/akram-bouchenaki\/\">Akram Bouchenaki<\/a>, Chief Executive Officer, Abdul Latif Jameel Health<em>. &nbsp;<\/em><\/p>\n\n\n\n<p><em>\u201cIt\u2019s our joint mission with EQRx to change that and, a mission that is aligned with the values of the Jameel Family.\u201d<\/em><\/p>\n\n\n<div class=\"wp-block-image wp-image-94300 size-medium\">\n<figure class=\"alignright\"><img decoding=\"async\" src=\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/EQRx_MelanieNallicheri_2020-200x300-1.jpg\" alt=\"Melanie Nallicheri, EQRx\" class=\"wp-image-94300\"\/><figcaption class=\"wp-element-caption\">Melanie Nallicheri<br><br>Chief Executive Officer, EQRx<\/figcaption><\/figure>\n<\/div>\n\n\n<p><em>\u201cThis strategic collaboration aims to expand the commercial reach of our lead oncology programs throughout the Middle East, Turkey and Africa and provide millions of people with access to affordable new cancer treatments,\u201d <\/em>said Melanie Nallicheri, Chief Executive Officer of EQRx.<\/p>\n\n\n\n<p><em>\u201cWe are excited to partner with Abdul Latif Jameel Health which brings extensive regulatory and commercial expertise in these vast regions as we continue to work to create sustainable access to innovative medicines globally.\u201d <\/em><\/p>\n\n\n\n<p>Abdul Latif Jameel Health also confirmed that it participated in previous funding rounds for EQRx through the dedicated <a href=\"https:\/\/jimco.com\/en\/funds\/life-sciences\/\">JIMCO Life Sciences Fund<\/a>, part of <a href=\"https:\/\/jimco.com\">JIMCO<\/a>, the <a href=\"https:\/\/jimco.com\/en\/who-we-are\/our-people\/#jameelfamily\">Jameel Family\u2019s<\/a> global investment arm.<\/p>\n","protected":false},"featured_media":3999,"menu_order":0,"template":"","class_list":["post-3997","pressrelease","type-pressrelease","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Abdul Latif Jameel Health to collaborate with EQRx to introduce two novel and affordable cancer treatments at a fraction of the cost of existing approaches to 1.5 billion people across the Middle East, Turkey and Africa - Abdul Latif Jameel<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abdul Latif Jameel Health to collaborate with EQRx to introduce two novel and affordable cancer treatments at a fraction of the cost of existing approaches to 1.5 billion people across the Middle East, Turkey and Africa - Abdul Latif Jameel\" \/>\n<meta property=\"og:description\" content=\"Abdul Latif Jameel Health, part of international diversified family business Abdul Latif Jameel, and EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at significantly lower prices, have entered into a new strategic collaboration for the commercialization of two affordable novel lung cancer therapeutics to millions of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/\" \/>\n<meta property=\"og:site_name\" content=\"Abdul Latif Jameel\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-09T09:02:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/towfiqu-barbhuiya-Yw9Vgr6i_-0-unsplash.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/\",\"url\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/\",\"name\":\"Abdul Latif Jameel Health to collaborate with EQRx to introduce two novel and affordable cancer treatments at a fraction of the cost of existing approaches to 1.5 billion people across the Middle East, Turkey and Africa - Abdul Latif Jameel\",\"isPartOf\":{\"@id\":\"https:\/\/10.0.2.222\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/towfiqu-barbhuiya-Yw9Vgr6i_-0-unsplash.jpg\",\"datePublished\":\"2021-11-22T06:54:42+00:00\",\"dateModified\":\"2025-12-09T09:02:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/#primaryimage\",\"url\":\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/towfiqu-barbhuiya-Yw9Vgr6i_-0-unsplash.jpg\",\"contentUrl\":\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/towfiqu-barbhuiya-Yw9Vgr6i_-0-unsplash.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/10.0.2.222\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abdul Latif Jameel Health to collaborate with EQRx to introduce two novel and affordable cancer treatments at a fraction of the cost of existing approaches to 1.5 billion people across the Middle East, Turkey and Africa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/10.0.2.222\/en\/#website\",\"url\":\"https:\/\/10.0.2.222\/en\/\",\"name\":\"Abdul Latif Jameel\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/10.0.2.222\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abdul Latif Jameel Health to collaborate with EQRx to introduce two novel and affordable cancer treatments at a fraction of the cost of existing approaches to 1.5 billion people across the Middle East, Turkey and Africa - Abdul Latif Jameel","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Abdul Latif Jameel Health to collaborate with EQRx to introduce two novel and affordable cancer treatments at a fraction of the cost of existing approaches to 1.5 billion people across the Middle East, Turkey and Africa - Abdul Latif Jameel","og_description":"Abdul Latif Jameel Health, part of international diversified family business Abdul Latif Jameel, and EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at significantly lower prices, have entered into a new strategic collaboration for the commercialization of two affordable novel lung cancer therapeutics to millions of [&hellip;]","og_url":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/","og_site_name":"Abdul Latif Jameel","article_modified_time":"2025-12-09T09:02:33+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/towfiqu-barbhuiya-Yw9Vgr6i_-0-unsplash.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/","url":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/","name":"Abdul Latif Jameel Health to collaborate with EQRx to introduce two novel and affordable cancer treatments at a fraction of the cost of existing approaches to 1.5 billion people across the Middle East, Turkey and Africa - Abdul Latif Jameel","isPartOf":{"@id":"https:\/\/10.0.2.222\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/#primaryimage"},"image":{"@id":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/#primaryimage"},"thumbnailUrl":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/towfiqu-barbhuiya-Yw9Vgr6i_-0-unsplash.jpg","datePublished":"2021-11-22T06:54:42+00:00","dateModified":"2025-12-09T09:02:33+00:00","breadcrumb":{"@id":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/#primaryimage","url":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/towfiqu-barbhuiya-Yw9Vgr6i_-0-unsplash.jpg","contentUrl":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/towfiqu-barbhuiya-Yw9Vgr6i_-0-unsplash.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/news\/abdul-latif-jameel-health-to-collaborate-with-eqrx-to-introduce-two-novel-and-affordable-cancer-treatments-at-a-fraction-of-the-cost-of-existing-approaches-to-1-5-billion-people-across-the-middle-east\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/10.0.2.222\/en\/"},{"@type":"ListItem","position":2,"name":"Abdul Latif Jameel Health to collaborate with EQRx to introduce two novel and affordable cancer treatments at a fraction of the cost of existing approaches to 1.5 billion people across the Middle East, Turkey and Africa"}]},{"@type":"WebSite","@id":"https:\/\/10.0.2.222\/en\/#website","url":"https:\/\/10.0.2.222\/en\/","name":"Abdul Latif Jameel","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/10.0.2.222\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"post-meta-fields":{"_published_date":["field_6057129b493f5"],"published_date":["20211122"],"_location":["field_601267396ce72"],"location":["Dubai, UAE"],"_featured":["field_601a3b473c5c5"],"featured":[""],"_footnotes":["field_66fd39afb9383"],"footnotes":[""],"_business_sector":["field_66f6b5bcac8cb"],"business_sector":["Health"],"_content_series":["field_66fe3c439f8f6"],"content_series":[""],"_old_post_id":["field_66fe3fd59f8f7"],"old_post_id":["94297"],"_short_title":["field_60925d67125ef"],"short_title":["Abdul Latif Jameel Health collaborates with EQRx"],"_summary":["field_6019304103a20"],"summary":["Abdul Latif Jameel Health, and EQRx have entered into a new strategic collaboration for the commercialization of two affordable novel lung cancer therapeutics to millions of people across the Middle East, Africa and Turkey"],"_mobile_featured_image":["field_66f6b4bee65f3"],"mobile_featured_image":["https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/towfiqu-barbhuiya-Yw9Vgr6i_-0-unsplash.jpg"],"_push_notification":["field_66f6b47de65f1"],"push_notification":[""],"_publish_mobile":["field_66f6b491e65f2"],"publish_mobile":["1"],"_status":["field_652694983fe12"],"status":["publish"],"_thumbnail_id":["3999"],"_wp_page_template":["default"],"_wpml_word_count":["{\"total\":531,\"to_translate\":{\"ar\":531,\"zh-hans\":531,\"fr\":531,\"ja\":531,\"es\":531,\"tr\":531}}"],"amazonS3_cache":["a:9:{s:72:\"\/\/cms.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Akram_Web-1.jpg\";a:2:{s:2:\"id\";s:4:\"4004\";s:11:\"source_type\";s:13:\"media-library\";}s:80:\"\/\/cms.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Akram_Web-200x300-1.jpg\";a:2:{s:2:\"id\";s:4:\"4004\";s:11:\"source_type\";s:13:\"media-library\";}s:82:\"\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Akram_Web-200x300-1.jpg\";a:2:{s:2:\"id\";s:4:\"4004\";s:11:\"source_type\";s:13:\"media-library\";}s:90:\"\/\/cms.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/EQRx_MelanieNallicheri_2020-1.jpg\";a:2:{s:2:\"id\";s:4:\"4001\";s:11:\"source_type\";s:13:\"media-library\";}s:98:\"\/\/cms.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/EQRx_MelanieNallicheri_2020-200x300-1.jpg\";a:2:{s:2:\"id\";s:4:\"4001\";s:11:\"source_type\";s:13:\"media-library\";}s:100:\"\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/EQRx_MelanieNallicheri_2020-200x300-1.jpg\";a:2:{s:2:\"id\";s:4:\"4001\";s:11:\"source_type\";s:13:\"media-library\";}s:74:\"\/\/cms.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Akram_Print-1.jpg\";a:2:{s:2:\"id\";s:4:\"4000\";s:11:\"source_type\";s:13:\"media-library\";}s:82:\"\/\/cms.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Akram_Print-200x300-1.jpg\";a:2:{s:2:\"id\";s:4:\"4000\";s:11:\"source_type\";s:13:\"media-library\";}s:84:\"\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Akram_Print-200x300-1.jpg\";a:2:{s:2:\"id\";s:4:\"4000\";s:11:\"source_type\";s:13:\"media-library\";}}"],"_wpml_location_migration_done":["1"],"_select_category":["field_6937c5cade1ee"],"select_category":["international"]},"_links":{"self":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/wp-json\/wp\/v2\/pressrelease\/3997","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/wp-json\/wp\/v2\/pressrelease"}],"about":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/wp-json\/wp\/v2\/types\/pressrelease"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/wp-json\/wp\/v2\/media\/3999"}],"wp:attachment":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/en\/wp-json\/wp\/v2\/media?parent=3997"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}